Skip to content

Clinical trials

Phase 3 Nervous System Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nervous System Diseases Phase: Phase 3 Country / region: Germany Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20132
20143
20151
20164
20172
20182
20191
20202
20211
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated4
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
GenSight Biologics3
AstraZeneca2
Auspex Pharmaceuticals, Inc.2
PTC Therapeutics2
Avidity Biosciences, Inc.1
Baxalta now part of Shire1
Eli Lilly and Company1
Hoffmann-La Roche1
Kyberg Vital GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nervous System Diseases22
Central Nervous System Diseases10
Neurodegenerative Diseases10
Brain Diseases8
Genetic Diseases, Inborn7
Movement Disorders6
Alzheimer Disease4
Dementia4
Eye Diseases4
Mental Disorders4

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.